Proxyvon

Quick links to important sections

Proxyvon

Method of action: Analgesic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proxyvon

Proxyvon: Definition and Type of Combination Analgesic

Property Description
Active Ingredients Dextropropoxyphene and Acetaminophen
Form Oral preparation (Capsule or Tablet)
Pharmacological Class Combination Analgesic
General Purpose Pain Relief (Dual-Action Analgesia)
Origin Synthetic

Proxyvon is defined as a prescription-only fixed-dose combination (FDC) analgesic that is intended for oral use, typically prepared as a capsule or tablet. This product is a blend of two distinct active, synthetic substances, which differentiates it from single-ingredient pain relievers. The combination structure is supported by pharmacological data, which historically recognized the Dextropropoxyphene/Acetaminophen pairing for addressing moderate pain when non-opioid options were insufficient.


What is Proxyvon Made Of? (Active Ingredients)

The active ingredients in Proxyvon are the international nonproprietary names (INN) Dextropropoxyphene and Acetaminophen (Paracetamol). Dextropropoxyphene is officially categorized as an opioid analgesic that acts on the central nervous system, and Acetaminophen is classified as a non-opioid analgesic and antipyretic agent.

This composition allows for two distinct physiological actions in a single dose. The Dextropropoxyphene component modifies the central perception of pain, while Acetaminophen works to reduce pain signaling by inhibiting prostaglandins. The final product is an oral preparation utilizing standard pharmaceutical excipients.


General Purpose of the Dual-Action Formulation

The general purpose of this dual-component formulation is to achieve comprehensive pain relief through complementary pathways. This dual-action strategy is rooted in the principle of pharmaceutical synergy, aiming for an enhanced analgesic effect. The formulation is intended to provide a potent pain-relieving effect by simultaneously addressing the transmission and central processing of discomfort.

What side effects are possible with Proxyvon?

The safety profile for the Dextropropoxyphene and Acetaminophen combination is defined by the officially documented adverse effects of its two active components, as categorized in government regulatory documents. Reactions are grouped by frequency and the physiological systems they affect.

Common adverse reactions, frequently observed, fall under Nervous System Disorders and Gastrointestinal Disorders. These include dizziness, drowsiness, nausea, vomiting, and constipation. These central effects are often most pronounced at the start of therapy.

Less frequently reported reactions (Uncommon) include abdominal pain and skin rash.

Serious Adverse Reactions and Constraints

Regulatory sources explicitly document several rare but life-threatening risks. These primarily involve Serious Cardiac Toxicity, including changes in the heart's electrical activity such (PR, QRS, and QT prolongation) that can lead to abnormal heart rhythms, even at therapeutic doses. Other severe risks include Respiratory Depression, which is the chief hazard of the opioid component, and Acute Liver Failure (Hepatotoxicity) due to the Acetaminophen component. The risk of Fatal Overdose is a major safety constraint, particularly when the drug is used concomitantly with other CNS depressants, including alcohol.

Population-Specific and Duration-Related Safety

Safety notes specify increased sensitivity in certain patient groups. Older adults may have increased susceptibility to central nervous system effects and a heightened risk of cardiac toxicity. Caution is required for individuals with Hepatic or Renal Impairment. Additionally, the development of Tolerance and Physical Dependence are safety concerns associated with prolonged use of the opioid component. The drug may also impair the mental and/or physical abilities required for operating machinery or driving.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with the Dextropropoxyphene/Acetaminophen combination presents two distinct, life-threatening toxicities: Opioid Toxicity and Hepatotoxicity. The immediate threat stems from the Dextropropoxyphene component, which can lead to profound CNS depression, including somnolence, respiratory depression, apnea, and subsequent cardiovascular collapse or cardiac arrest. The Acetaminophen component carries a risk of acute hepatic failure and hepatic necrosis, which may have a delayed onset but can be fatal.

Required Emergency Actions

The official regulatory guidance requires immediate medical attention for all suspected or confirmed overdoses, regardless of the initial presence or severity of symptoms. Individuals must contact the poison control center immediately and be transported to a hospital emergency room without delay.

Management involves specific interventions targeting both agents. A specific opioid antagonist (naloxone) is indicated for Dextropropoxyphene toxicity, while N-acetylcysteine (NAC) is required to manage the Acetaminophen toxicity. Continuous monitoring of respiratory and cardiac status is necessary. Immediate hospitalization is required for assessment, along with monitoring of plasma Acetaminophen levels and liver enzyme function. Overdose in pediatric patients is noted to be potentially more severe.

Therapeutic Uses of Proxyvon

What Proxyvon Treats: Main Uses and Benefits

The Dextropropoxyphene and Acetaminophen combination is relevant in clinical settings marked by heightened patient distress, offering symptomatic assistance across key therapeutic domains. This formulation is commonly used to help with mild to moderate pain.

The medication is generally used for managing symptoms related to physical discomfort that may interfere with daily functioning, including musculoskeletal aches, headaches, acute dental pain, and menstrual cramps (dysmenorrhea). This is relevant when supportive symptom management is appropriate, especially during episodes where symptoms become more noticeable.

“It provides necessary support that helps ease the overall symptom burden when discomfort creates noticeable functional strain.”

The dual formulation is applied in addressing situations where symptoms related to physical discomfort are accompanied by signs of systemic imbalance, such as fever. Providing relief for both pain and elevated body temperature, the medication contributes to improved comfort and assists with maintaining functional stability when symptoms are more disruptive.


Quick Fact: Relief for Moderate Pain and Fever

Regulatory References

  1. NIH DailyMed official information

Eligibility and Restrictions for Use

The eligibility profile for the Dextropropoxyphene/Acetaminophen combination (Proxyvon) is highly restricted by regulatory authorities, largely due to the risk of cardiotoxicity associated with the propoxyphene component, which led to its withdrawal from major markets like the US and EU.

Contraindicated Populations

Use of this medicine is strictly prohibited (contraindicated) for individuals with known hypersensitivity to the active ingredients or those with severe, pre-existing conditions. These include significant respiratory depression, severe asthma, and paralytic ileus. Due to its opioid component, it is also contraindicated in patients with a history of substance abuse or suicidal ideation. It must not be used by patients with severe hepatic impairment.

Age and Condition Restrictions

Use is not recommended for older adults (geriatric patients over 65) because reduced clearance of the active metabolite significantly increases the risk of heart-related toxicity. Safety and efficacy have not been established for pediatric populations. Caution is required for patients with renal insufficiency or non-severe liver disorders. Use is restricted during pregnancy, and use while breastfeeding is generally not recommended.

What should I know about interactions with other medicines?

Proxyvon Interactions with other medicines and products

The official regulatory profile for Dextropropoxyphene/Acetaminophen specifies interactions that significantly impact both drug clearance and overall central nervous system activity.


Interaction Classifications and Restrictions

The co-administration of this product with Opioid Agonist-Antagonists (e.g., pentazocine, nalbuphine) is associated with a risk of reducing the analgesic effect or precipitating withdrawal symptoms. Use is also restricted with other Acetaminophen-Containing Products to mitigate the risk of acute liver failure from exceeding the documented maximum daily amount.

Pharmacokinetic and Pharmacodynamic Effects

  • CNS Depressants: Co-administration with Alcohol or other CNS Depressants (such as sedatives, tranquilizers, and muscle relaxants) is officially documented to result in additive central nervous system depression, including profound sedation and respiratory depression. Agents that compromise vasomotor tone (e.g., phenothiazines) may cause severe hypotension. Chronic use of the Acetaminophen component with Sodium Warfarin has been shown to increase the International Normalized Ratio (INR).
  • CYP Enzymes: Strong CYP3A4 Inhibitors (including certain antivirals and Grapefruit Juice) are documented to increase Dextropropoxyphene plasma levels by reducing its metabolic clearance. Dextropropoxyphene is also an inhibitor of CYP3A4 and CYP2D6, which is officially stated to increase the exposure of co-administered medicines that are substrates for these enzymes.
  • Population Notes: Patients with severe hepatic impairment or severe renal impairment (CrCl le 30 mL/min) are cited as having heightened interaction or toxicity risks due to altered drug disposition.

Mechanism of Action

Proxyvon is a combination medication that exerts its action across three distinct pharmacodynamic domains, influencing both central neurotransmission and peripheral smooth muscle contractility.

Central Opioid Receptor Modulation

The Tramadol component functions as an opioid agonist at mu-opioid receptors within the central nervous system (CNS). This interaction modulates the transmission of nociceptive signals via ascending and descending pain pathways, altering the central processing of neural input.

Central Prostaglandin Synthesis Inhibition

Paracetamol (Acetaminophen) modulates key steps, primarily in the CNS, by inhibiting the synthesis of prostaglandins. Prostaglandins are lipid mediators that influence systemic physiological responses. By suppressing their central formation, this pathway attenuates the synthesis of inflammatory and pyretic mediators.

Gastrointestinal Smooth Muscle Modulation

Dicyclomine acts as an anticholinergic agent. It operates via competitive antagonism at muscarinic acetylcholine receptors on smooth muscle cells, particularly within the gastrointestinal tract. This mechanism regulates involuntary muscle contractions, influencing motor activity and visceral tonus.

The combined action influences multiple target systems, leading to modified nociceptive processing and altered smooth muscle activity.

Dosage and Administration Information

The administration of Proxyvon (referring to the Tramadol/Paracetamol combination formula) must strictly follow the official instructions provided by a prescribing healthcare professional.


Official Administration Guidelines

Administration Scope Instruction
Route of Administration Oral (by mouth)
Dosing Schedule Initial dose is typically 2 tablets every 4 to 6 hours as needed for pain relief, up to a maximum of 8 tablets per day. The lowest effective dose should be selected.
Timing in Relation to Meals Can be taken with or without food. Taking with food or milk may help minimize stomach upset.
Special Procedural Conditions The tablet or capsule must be swallowed whole with a sufficient quantity of liquid. It must not be cut, crushed, or chewed.

Dose Management

The medicine is generally indicated for short-term use only, not exceeding five days, unless otherwise directed by a physician.

  • Missed-Dose Instructions: If a dose is missed, skip the missed dose and continue with the regular dosing schedule. Do not take a double dose to make up for a missed one.
  • Age-Group Rules: The medicine is not recommended for use in children younger than 12 years of age.

These official directives establish a standardized protocol for use, ensuring that the dose and frequency are precisely controlled and that the method of ingestion (swallowing whole) is maintained for the product to function as intended.

Recent Clinical Evidence

Research Focus: Acute Pain and Analgesic Studies

The primary research base for the Dextropropoxyphene/Acetaminophen combination consists of numerous Randomized Controlled Trials (RCTs), many of which employed short-term, single-dose, double-blind designs. These studies were applied to examine patient-reported experiences in adult populations recovering from acute events, such as post-surgical or postpartum discomfort. Research examined measurements of change in pain intensity and the duration of observed effects. Trials also was studied for conditions characterized by fluctuating manifestations, such as neurogenic claudication and soft-tissue disorders.

Findings from systematic reviews indicate that while the combination’s short-term profile is characterized by the data, comparative evidence is lacking, and findings were mixed regarding superiority to Acetaminophen alone.


Evidence in Special Patient Populations

Research examined available data for certain patient cohorts, including a focus on older adults. Dedicated studies exploring how symptoms change over time in children or in patients with certain comorbid conditions are often lacking. Regulators have noted that data for certain groups remain insufficient, meaning the results apply only to the populations studied in the original trials.


Limitations in Research Duration and Uncertainty

A significant limitation in the research is that follow-up durations were limited, typically spanning only four to eight hours after a single dose. This time frame is sufficient for analyzing acute effects, but there is limited information for long-term outcomes or consistent use in chronic conditions.

Furthermore, much of the research was observed in studies conducted decades ago, and the long-term effects are not fully established. This contributes to the finding that scientific certainty remains low in some comparisons, especially regarding persistent use.

Key Studies & References Propoxyphene Hydrochloride and Acetaminophen tablet - DailyMed (NIH Monograph - Historical Prescribing Information)

Frequently Asked Questions (FAQ)

Common questions about Proxyvon (FAQ)


Q: Is Proxyvon used to treat conditions other than pain?

Proxyvon is defined as a combination analgesic product, and its general purpose, according to regulatory documents, is pain relief. However, one of its active ingredients, Acetaminophen, is also officially classified as an antipyretic agent, which means it is used to help reduce fever.


Q: Why do some people say Proxyvon is 'stronger' than over-the-counter options?

The drug's structure, which combines an opioid analgesic (Dextropropoxyphene) and a non-opioid analgesic (Acetaminophen) in a single dose, is intended to achieve an enhanced pain-relieving effect through complementary pathways. Official information confirms this dual-action strategy.


Q: Do the side effects of Proxyvon go away after a few days of use?

Official safety information notes that the common central nervous system effects, such as dizziness and drowsiness, are often most pronounced at the start of therapy. The information indicates that these effects are often most pronounced at the start of therapy, without providing a guarantee that they will lessen over time.


Q: Does Proxyvon interact with common cold or flu medications?

Official warnings state that this drug should not be used with other products that contain Acetaminophen to avoid the risk of acute liver failure. Warnings also exist for co-administration with other Central Nervous System (CNS) depressants, which carry a risk of increased sedation.


Q: Are there any specific vitamins or supplements that interact with Proxyvon?

Regulatory documents state that Grapefruit Juice can affect the metabolism of the Dextropropoxyphene component, potentially increasing the body’s exposure to the drug. Chronic use of the Acetaminophen component with the blood thinner Sodium Warfarin is also documented to increase a blood clotting measure (INR).


Q: Does Proxyvon contain any common allergens like gluten or lactose?

The label mandates allergy warnings for severe skin reactions caused by the Acetaminophen component. The product is stated to be an oral preparation utilizing standard pharmaceutical excipients, but specific common allergens like gluten or lactose are not typically listed in the core regulatory summary.


Q: What is the difference between the brand name Proxyvon and a generic version?

All generic versions of this medicine must contain the identical two active ingredients—Dextropropoxyphene and Acetaminophen—in the same dose and form as the brand product. Regulatory information focuses on the drug substance, while differences may relate to inactive ingredients or commercial factors.


Q: What is the typical timeframe for a doctor to review Proxyvon usage?

The official product indication specifies that this medicine is generally intended for short-term use only, not exceeding five days. The short recommended usage duration is a factor in treatment monitoring.


Q: How quickly does Proxyvon start to work after I take it?

Clinical data indicates that the pain-relieving effect of the propoxyphene component begins within 20–30 minutes after taking the oral dose. The peak effect is generally reported in clinical data to occur between 1.5 to 2.0 hours.


Q: What is the difference between Proxyvon and standard pain relievers?

Proxyvon is a combination product that contains two different types of active pain relievers: an opioid and a non-opioid. Many standard pain relievers, such as ibuprofen or basic acetaminophen, typically contain only one active ingredient, which gives Proxyvon two distinct mechanisms of action.


Q: What kind of severe side effects should I be aware of?

Official regulatory warnings identify the risk of several serious side effects. These include Serious Cardiac Toxicity (changes in heart rhythm), severe Respiratory Depression (the primary risk of the opioid component), and Acute Liver Failure (hepatotoxicity due to the Acetaminophen component).


Q: Is Proxyvon a controlled substance in the country I live in?

In the United States, the propoxyphene and acetaminophen combination is officially designated as a Schedule IV narcotic under the Controlled Substances Act. This classification indicates that the drug has an accepted medical use but also carries a potential for abuse or dependence and requires secure storage.


Q: Are there any dietary restrictions while taking Proxyvon?

The primary restriction, as noted in official warnings, is the prohibition of alcohol consumption, as this greatly increases the risk of severe central nervous system depression and overdose. The consumption of Grapefruit Juice is also documented to increase exposure to the drug's active component.


Q: What is the risk of accidental overdose with Proxyvon?

Regulatory documents explicitly warn of a high risk of accidental and intentional overdose, noting that the risk of fatalities increases, especially when the drug is taken with other central nervous system depressants.


Q: How does the body process and eliminate Proxyvon?

The active ingredients are processed by enzymes in the liver and changed into substances called metabolites, one of which (norpropoxyphene) is active. These substances are ultimately eliminated from the body, mostly through the urine.


Q: Does Proxyvon come in different strengths or formulations?

According to official documentation on dosage forms and strengths, this combination product has historically been available as an oral capsule or tablet. It has also been manufactured in different dose combinations of the two active ingredients.


Q: What is the clinical definition of the pain Proxyvon is intended to treat?

Official documents state the product is indicated for the management of mild to moderate pain. It has also been indicated for the management of moderate to severe pain when used alongside other opioid analgesics.


Q: Do studies suggest Proxyvon is more effective for acute or chronic pain?

The research base consists primarily of short-term trials examining acute pain. Official documents note that there is limited information regarding the drug's outcomes for chronic pain conditions, and it is generally indicated for short-term use.


Q: Why is the drug given a specific safety classification?

The drug's safety classification and withdrawal from major markets are primarily due to the officially documented risk of Serious Cardiac Toxicity, which can lead to abnormal heart rhythms, and the risk of Fatal Overdose. These risks were noted to occur even when the drug was used at or near the prescribed therapeutic dose.

How should Proxyvon be stored and disposed of?

How to Store and Dispose of Proxyvon

The storage and disposal of Proxyvon (Dextropropoxyphene/Acetaminophen) are strictly governed by regulatory requirements, primarily because Dextropropoxyphene is classified as a controlled substance.

Storage Conditions

Requirement Official Labeled Mandate
Temperature Store at controlled room temperature: 20 C to 25 C (68 F to 77 F).
Protection Keep tightly closed. Protect from excessive heat, light, and moisture.
Security Must be kept out of the sight and reach of children and stored securely.

Disposal Instructions

To prevent misuse and diversion, unused or expired Proxyvon must be disposed of safely. The preferred method is a DEA-authorized drug take-back program. If unavailable, discard in the household trash by first mixing the product with an undesirable substance (such as used coffee grounds or dirt) and placing the mixture in a sealed container. This product is not recommended for flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proxyvon found in:

A-Z Index: